Cellectis
CLLS
$2.56
Share price
1.59%
Change (1 day)
31.28%
Change (1 year)
Categories
Cellectis (CLLS) - Net assets
Net assets on the balance sheet as of September 2023 : $76.12 M
According to Cellectis's latest financial reports the company has $76.12 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Cellectis - Net assets on balance sheet (from 2008 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $0.12 B | -46.74% |
| 2021-12-31 | $0.23 B | -23.43% |
| 2020-12-31 | $0.30 B | -13.12% |
| 2019-12-31 | $0.35 B | -21.05% |
| 2018-12-31 | $0.45 B | 58.55% |
| 2017-12-31 | $0.28 B | 3.39% |
| 2016-12-31 | $0.27 B | -4.7% |
| 2015-12-31 | $0.28 B | 298.17% |
| 2014-12-31 | $72.38 M | 1982.65% |
| 2013-12-31 | $3.47 M | -95.08% |
| 2012-12-31 | $70.68 M | 90.94% |
| 2011-12-31 | $37.02 M | -25.73% |
| 2010-12-31 | $49.84 M | -23.06% |
| 2009-12-31 | $64.78 M | 40.24% |
| 2008-12-31 | $46.19 M | 6.09% |
| 2007-12-31 | $43.54 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Regeneron Pharmaceuticals REGN | $25.97 B | 34,019.91% | 🇺🇸 USA |
 uniQure QURE | $0.20 B | 172.81% | 🇳🇱 Netherlands |
 Novavax NVAX | -$0.72 B | -1,041.80% | 🇺🇸 USA |